|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.8 TWD | +1.27% |
|
+1.82% | -25.10% |
GeneFerm Biotechnology Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 183.76 million compared to TWD 143.91 million a year ago. Net income was TWD 30.47 million compared to TWD 20.5 million a year ago.
Basic earnings per share from continuing operations was TWD 0.73 compared to TWD 0.5 a year ago. Diluted earnings per share from continuing operations was TWD 0.73 compared to TWD 0.46 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -25.10% | 70.92M | |
| -4.93% | 261B | |
| -2.51% | 94.98B | |
| +3.19% | 46.39B | |
| +8.74% | 39.99B | |
| -0.65% | 39.95B | |
| -0.15% | 38.02B | |
| -16.78% | 30.16B | |
| -6.61% | 28.72B | |
| +11.32% | 24.54B |
GENEFERM BIOTECHNOLOGY CO., LTD. 
